129 related articles for article (PubMed ID: 38682845)
1. Antinuclear antibody titration and pattern are helpful in the diagnosis of systemic autoimmune rheumatic diseases.
Mohd Razi MS; Sugumaran Y; Mohd Haniz NA; Khilmie K; Osmera AH; Jauhary EJ; Wahab AA
Malays J Pathol; 2024 Apr; 46(1):63-69. PubMed ID: 38682845
[TBL] [Abstract][Full Text] [Related]
2. Clinical Aspects of the Dense Fine Speckled Pattern in Indirect Immunofluorescence-Antinuclear Antibody Screening and Its Association with DFS70 Autoantibodies.
La Jeon Y; Kang SY; Lee WI; Kim MH
Ann Clin Lab Sci; 2019 Sep; 49(4):496-502. PubMed ID: 31471339
[TBL] [Abstract][Full Text] [Related]
3. The antinuclear antibody dense fine speckled pattern and possible clinical associations: An indication of a proinflammatory microenvironment.
Lundgren MC; Sapkota S; Peterson DJ; Crosson JT
J Immunol Methods; 2021 Jan; 488():112904. PubMed ID: 33121975
[TBL] [Abstract][Full Text] [Related]
4. Dense fine speckled immunofluorescence pattern in a Chinese population: Prevalence and clinical association.
Zhang K; Su Z; Hu J; Huang Z; Hu C; Yang B
J Clin Lab Anal; 2022 Feb; 36(2):e24173. PubMed ID: 34952992
[TBL] [Abstract][Full Text] [Related]
5. Dense fine speckled indirect immunofluorescence pattern in an Australian population.
Broadfoot A; Sivertsen T; Baumgart K
Pathology; 2016 Apr; 48(3):247-50. PubMed ID: 27020500
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
Yang Z; Ren Y; Liu D; Lin F; Liang Y
APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the analytical and clinical performances of two different routine testing protocols for antinuclear antibody screening.
González Rodríguez C; Fuentes Cantero S; Pérez Pérez A; Vázquez Barbero FJ; León Justel A
J Clin Lab Anal; 2021 Sep; 35(9):e23914. PubMed ID: 34347308
[TBL] [Abstract][Full Text] [Related]
8. Algorithm for antinuclear antibodies in subjects with clinical suspicion of autoimmune diseases.
Naranjo L; Shovman O; Pérez D; Infantino M; Cabrera-Marante O; Lozano F; Gilburd B; Manfredi M; Serrano M; Morillas L; Shoenfeld Y; Serrano A
Clin Exp Rheumatol; 2020; 38(4):633-639. PubMed ID: 31694754
[TBL] [Abstract][Full Text] [Related]
9. Automated antinuclear immunofluorescence antibody screening: a comparative study of six computer-aided diagnostic systems.
Bizzaro N; Antico A; Platzgummer S; Tonutti E; Bassetti D; Pesente F; Tozzoli R; Tampoia M; Villalta D;
Autoimmun Rev; 2014 Mar; 13(3):292-8. PubMed ID: 24220268
[TBL] [Abstract][Full Text] [Related]
10. Negative ANA-IIF in SLE patients: what is beyond?
Abozaid HSM; Hefny HM; Abualfadl EM; Ismail MA; Noreldin AK; Eldin ANN; Goda AM; Ali AH
Clin Rheumatol; 2023 Jul; 42(7):1819-1826. PubMed ID: 37016193
[TBL] [Abstract][Full Text] [Related]
11. [Investigation of the diagnostic value of anti-dense fine speckled 70/lens epithelium derived growth factor p75 autoantibody for autoimmune diseases].
Türkoğlu G; Berkem R; Karakoç AE
Mikrobiyol Bul; 2018 Oct; 52(4):413-424. PubMed ID: 30522426
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of anti-DFS70 antibodies in a cohort of patients undergoing routine antinuclear antibodies testing.
Yumuk Z; Demir M
J Immunol Methods; 2020 May; 480():112754. PubMed ID: 32057435
[TBL] [Abstract][Full Text] [Related]
13. Clinical phenotypes of patients with anti-DFS70/LEDGF antibodies in a routine ANA referral cohort.
Miyara M; Albesa R; Charuel JL; El Amri M; Fritzler MJ; Ghillani-Dalbin P; Amoura Z; Musset L; Mahler M
Clin Dev Immunol; 2013; 2013():703759. PubMed ID: 23476678
[TBL] [Abstract][Full Text] [Related]
14. The importance of detecting anti-DFS70 in routine clinical practice: comparison of different care settings.
Bonroy C; Schouwers S; Berth M; Stubbe M; Piette Y; Hoffman I; Devreese K; Van Hoovels L
Clin Chem Lab Med; 2018 Jun; 56(7):1090-1099. PubMed ID: 29427547
[TBL] [Abstract][Full Text] [Related]
15. Identification of specific antinuclear antibodies in dogs using a line immunoassay and enzyme-linked immunosorbent assay.
Bremer HD; Lattwein E; Renneker S; Lilliehöök I; Rönnelid J; Hansson-Hamlin H
Vet Immunol Immunopathol; 2015 Dec; 168(3-4):233-41. PubMed ID: 26547884
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of antinuclear antibodies by indirect immunofluorescence and line immunoassay methods': four years' data from Turkey.
Sener AG; Afsar I; Demirci M
APMIS; 2014 Dec; 122(12):1167-70. PubMed ID: 24735346
[TBL] [Abstract][Full Text] [Related]
17. Reconstructing a 3-dimensional image of the results of antinuclear antibody testing by indirect immunofluorescence.
Murai R; Yamada K; Tanaka M; Kuribayashi K; Kobayashi D; Tsuji N; Watanabe N
J Immunol Methods; 2013 Jan; 387(1-2):312-6. PubMed ID: 23073364
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of ELISA methods as an alternative screening test to indirect immunofluorescence for the detection of antinuclear antibodies. Evaluation of five commercial kits.
Tonuttia E; Bassetti D; Piazza A; Visentini D; Poletto M; Bassetto F; Caciagli P; Villalta D; Tozzoli R; Bizzaro N
Autoimmunity; 2004 Mar; 37(2):171-6. PubMed ID: 15293886
[TBL] [Abstract][Full Text] [Related]
19. Antinuclear antibodies (ANAs) detected by indirect immunofluorescence (IIF) method in acute COVID-19 infection; future roadmap for laboratory diagnosis.
Peker BO; Şener AG; Kaptan Aydoğmuş F
J Immunol Methods; 2021 Dec; 499():113174. PubMed ID: 34737165
[TBL] [Abstract][Full Text] [Related]
20. Analysis of antinuclear antibody titers and patterns by using HEp-2 and primate liver tissue substrate indirect immunofluorescence assay in patients with systemic autoimmune rheumatic diseases.
Wei Q; Jiang Y; Xie J; Lv Q; Xie Y; Tu L; Xiao M; Wu Z; Gu J
J Clin Lab Anal; 2020 Dec; 34(12):e23546. PubMed ID: 33047841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
